Search results
Results from the WOW.Com Content Network
Targeted Therapy Database (TTD) from the Melanoma Molecular Map Project Targeted therapy Fact sheet from the U.S. National Cancer Institute Molecular Oncology: Receptor-Based Therapy Special issue of Journal of Clinical Oncology (April 10, 2005) dedicated to targeted therapies in cancer treatment
Molecular medicine is a new scientific discipline in European universities. [11] Combining contemporary medical studies with the field of biochemistry , it offers a bridge between the two subjects. At present only a handful of universities offer the course to undergraduates .
Molecular Therapy is a scientific journal, published by Cell Press, that aims to develop and explore "molecular and cellular therapeutics to correct genetic and acquired diseases". [ 1 ] The founder of the journal and its Editor-in-Chief in the first five years was Inder Verma .
MDPI (Multidisciplinary Digital Publishing Institute) is a publisher of open-access scientific journals.It publishes over 390 peer-reviewed, open-access journals. [2] [3] MDPI is among the largest publishers in the world in terms of journal article output, [4] [5] and is the largest publisher of open access articles.
The International Journal of Molecular Sciences is a peer-reviewed open access scientific journal covering research in chemistry, molecular physics, and molecular biology. It is published by MDPI and was established in 2000. The journal is considered one of MDPI's flagship publications. [1]
This is a type of targeted therapy which uses the physical, chemical and biological properties of the radiopharmaceutical to target areas of the body for radiation treatment. [3] The related diagnostic modality of nuclear medicine employs the same principles but uses different types or quantities of radiopharmaceuticals in order to image or ...
Current Molecular Medicine is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Andras Guttman ( University of Pannonia ). The journal covers research on molecular mechanisms of disease pathogenesis , the development of molecular diagnosis , and/or novel approaches to rational treatment.
Targeted therapy of lung cancer refers to using agents specifically designed to selectively target molecular pathways responsible for, or that substantially drive, the malignant phenotype of lung cancer cells, and as a consequence of this (relative) selectivity, cause fewer toxic effects on normal cells.